# MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

> **NCT07362225** · — · RECRUITING · sponsor: **MPN Research Foundation** · enrollment: 5000 (estimated)

## Conditions studied

- Polycythemia Vera
- ET (Essential Thrombocythemia)
- Polycythemia Vera (PV)
- Essential Thrombocythemia (ET)
- Primary Myelofibrosis (MF)
- Primary Myelofibrosis (PMF)
- Myelofibrosis
- Myelofibrosis (MF)
- Myelofibrosis, Primary
- Myelofibrosis, Post ET
- Myelofibrosis, Post PV
- Myelofibrosis (PMF)
- Myelofibrosis，MF
- Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
- Myelofibrosis Due to and Following Polycythemia Vera
- Myelofibrosis Transformation in Essential Thrombocythemia
- Myelofibrosis With High Molecular Risk Mutations
- MF
- Secondary Myelofibrosis
- Secondary Myelofibrosis in Myeloproliferative Disease
- Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis)
- Post-Polycythemia Vera Myelofibrosis
- Post-polycythemia Vera Myelofibrosis (PPV-MF)
- Post-polycythemia Vera Myelofibrosis (Post-PV MF)
- Post-polycythemia Vera Myelofibrosis(Post-PV MF)
- Post-PV MF
- Post-Essential Thrombocythemia Myelofibrosis
- Post-essential Thrombocythemia Myelofibrosis (PET-MF)
- Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)
- Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
- Post-ET MF
- Pre-fibrotic Myelofibrosis
- Myeloproliferative Disorder
- Myeloproliferative Disorders
- Myeloproliferative Disorders (MPD)
- Myeloproliferative Neoplasms (MPNs)
- Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
- Myeloproliferative Neoplasm With 10% Blasts or Higher
- Myeloproliferative Neoplasms
- MPN
- MPN (Myeloproliferative Neoplasms)
- MPN-associated Myelofibrosis
- Myeloproliferative Neoplasm, Unclassifiable
- Myeloproliferative Neoplasm, Not Otherwise Specified
- Accelerated Phase MPN
- Accelerated Phase Myeloproliferative Neoplasm
- Blast Phase MPN
- Blast Phase Myeloproliferative Neoplasm
- Thrombocythemia Myelofibrosis (PET-MF)
- Thrombocythemia, Essential
- Thrombocythemia, Hemorrhagic
- Agnogenic Myeloid Metaplasia
- Chronic Idiopathic Myelofibrosis
- Idiopathic Myelofibrosis
- MDS/MPN Crossover Syndromes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07362225
- **Lead sponsor:** MPN Research Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-26
- **Primary completion:** 2035-09-08
- **Final completion:** 2035-09-08
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-01-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07362225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07362225, "MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07362225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*